Blair Lapointe
Direttore/Membro del Consiglio presso Dose Therapeutics, Inc.
Posizioni attive di Blair Lapointe
Società | Posizione | Inizio | Fine |
---|---|---|---|
Dose Therapeutics, Inc.
Dose Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Dose Therapeutics, Inc. is an early-stage biotechnology company based in Dallas, TX. Dose Therapeutics focuses on providing solutions for unmet medical needs, with a particular focus on high-risk neuroblastoma, an aggressive and often deadly form of childhood cancer. The company's first development candidate uses the tagging of a protein for degradation to potentially provide a new treatment option for children suffering from neuroblastoma. The company was founded by Steven L. McKnight and Deepak Nijhawan. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Blair Lapointe
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Posizioni
Director/Board Member | 1 |
Settori
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Dose Therapeutics, Inc.
Dose Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Dose Therapeutics, Inc. is an early-stage biotechnology company based in Dallas, TX. Dose Therapeutics focuses on providing solutions for unmet medical needs, with a particular focus on high-risk neuroblastoma, an aggressive and often deadly form of childhood cancer. The company's first development candidate uses the tagging of a protein for degradation to potentially provide a new treatment option for children suffering from neuroblastoma. The company was founded by Steven L. McKnight and Deepak Nijhawan. | Commercial Services |
- Borsa valori
- Insiders
- Blair Lapointe
- Esperienza